Skip to main content
Premium Trial:

Request an Annual Quote

Schering-Plough Research Institute Licenses Deltagen s Gene Function Database

SAN FRANCISCO, April 25 - Deltagen will provide Schering-Plough Research Institute with access to its database and intellectual property rights to develop and commercialize products, the companies said Thursday.


In the agreement, Schering-Plough Research Institute, the pharmaceutical research arm of Schering-Plough, will have access to Deltagen's DeltaBase in vivo mammalian gene function database. This will include rights to use knockout mice and data for internal research, including G protein-coupled receptor gene data, according to Deltagen.


Financial details of the agreement were not disclosed, though Deltagen said it would receive milestone payments in exchange for DeltaBase intellectual property rights for the development and commercialization of products.


The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.